## **Core Concept**
The peroxisome proliferator-activated receptors (PPARs) are a group of **nuclear hormone receptors** that play a crucial role in regulating genes involved in **glucose and lipid metabolism**. PPARs are ligand-activated transcription factors that influence various physiological processes, including glucose uptake, lipid storage, and cell differentiation.

## **Why the Correct Answer is Right**
The correct answer, **Fibrates**, are a class of drugs that act as ligands for **PPAR-alpha (PPAR-α)**, a subtype of PPARs. PPAR-α is primarily involved in the regulation of **lipid metabolism**, including fatty acid oxidation and lipoprotein metabolism. Fibrates, such as fenofibrate and gemfibrozil, activate PPAR-α, leading to increased lipolysis and elimination of triglyceride-rich particles from the plasma.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Sulfonylureas are a class of drugs used to treat type 2 diabetes by stimulating insulin release from pancreatic beta cells. They do not act as ligands for PPARs.
* **Option B:** Statins are HMG-CoA reductase inhibitors used to lower cholesterol levels. They do not have a direct effect on PPARs.
* **Option D:** Thiazolidinediones (TZDs) are a class of drugs that act as ligands for **PPAR-gamma (PPAR-γ)**, another subtype of PPARs. While TZDs do interact with PPARs, they are not the correct answer because the question seems to focus on a broader category of ligands, and fibrates are more directly associated with PPAR-α.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **fibrates** are used to treat **hypertriglyceridemia** and **mixed dyslipidemia**. They work by activating **PPAR-α**, which increases lipoprotein lipase activity, reducing triglyceride levels. A classic clinical correlation is that fibrates can increase the risk of **myopathy** when combined with statins.

## **Correct Answer:** C. Fibrates